In the context of cardiac hypertrophy, GDF-15 works through both Smad-dependent signaling (like Smad2/3) and alternative, non-Smad routes such as MAPK and TAK1 pathways [101,102]. Here, GDF15 is linked to cardiac hypertrophy.